Wolverine Trading
RDY icon

Wolverine Trading’s Dr. Reddy's Laboratories RDY Stock Holding History

Wolverine Trading’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-27,500
Closed -$273K – 5022
2016
Q2 		$273K Buy
+27,500
New +$252K ﹤0.01% 2897

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wolverine Trading's RDY Position: Q4 2021 in Review

Wolverine Trading sold out of Dr. Reddy's Laboratories (RDY) in Q4 2021, closing a stake of 15,450 shares — an estimated $201K sold.

Wolverine Trading first reported a position in RDY in Q2 2017 and held it in 4 quarters. The position peaked at $320K in Q2 2018. 147 funds tracked by Wall St. Rank hold RDY as of Q4 2021.

  • Wolverine Trading reported no remaining Dr. Reddy's Laboratories position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 15,450 Dr. Reddy's Laboratories shares in Q4 2021, an estimated $201K.
  • Wolverine Trading first reported a position in Dr. Reddy's Laboratories in Q2 2017 and held it in 4 quarters.
  • Wolverine Trading's Dr. Reddy's Laboratories position peaked at $320K in Q2 2018.
  • 147 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.